SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/29/20 Anthem, Inc. 10-Q 3/31/20 98:13M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 1.60M 2: EX-4.8 Instrument Defining the Rights of Security Holders HTML 49K 3: EX-10.2(L) Material Contract HTML 89K 4: EX-10.2(M) Material Contract HTML 91K 5: EX-10.2(N) Material Contract HTML 90K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 36K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 35K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 30K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 30K 16: R1 Document And Entity Information Document HTML 82K 66: R2 Consolidated Balance Sheets HTML 135K 79: R3 Consolidated Balance Sheets (Parenthetical) HTML 56K 47: R4 Consolidated Statements Of Income HTML 104K 19: R5 Consolidated Statements of Comprehensive Income HTML 57K 69: R6 Consolidated Statements Of Cash Flows HTML 126K 82: R7 Consolidated Statements Of Shareholders' Equity HTML 76K 48: R8 Organization HTML 35K 15: R9 Basis Of Presentation and Significant Accounting HTML 62K Policies 83: R10 Business Acquisitions HTML 34K 72: R11 Investments HTML 278K 26: R12 Derivative Financial Instruments Derivative HTML 33K Financial Instruments 55: R13 Fair Value HTML 327K 84: R14 Income Taxes HTML 32K 73: R15 Retirement Benefits HTML 56K 27: R16 Medical Claims Payable HTML 154K 56: R17 Debt HTML 48K 85: R18 Commitments And Contingencies HTML 62K 71: R19 Capital Stock HTML 105K 29: R20 Accumulated Other Comprehensive Income HTML 90K 37: R21 Earnings Per Share HTML 41K 89: R22 Segment Information HTML 129K 57: R23 Leases HTML 68K 31: R24 Basis of Presentation and Significant Accounting HTML 80K Policies (Policies) 38: R25 Investments (Tables) HTML 279K 90: R26 Fair Value (Tables) HTML 313K 58: R27 Retirement Benefits (Tables) HTML 55K 28: R28 Medical Claims Payable (Tables) HTML 159K 39: R29 Debt (Tables) HTML 35K 54: R30 Capital Stock (Tables) HTML 112K 24: R31 Accumulated Other Comprehensive Income (Tables) HTML 91K 75: R32 Earnings Per Share (Tables) HTML 38K 87: R33 Segment Information (Tables) HTML 133K 53: R34 Leases (Tables) HTML 71K 23: R35 Organization (Details) HTML 33K 74: R36 Basis of Presentation and Signficant Accounting HTML 44K Policies Basis of Presentation and Significant Acconting Policies (Details) 86: R37 Business Acquisitions Business Acquisition (Assets HTML 49K Liabilities Acquired) (Details) 52: R38 Investments (Current And Long-Term Fixed Maturity HTML 86K Securities, Available-For-Sale) (Details) 25: R39 Investments (Aggregate Fair Value And Gross HTML 73K Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details) 44: R40 Investments (Allowance For Credit Loss HTML 37K Rollforward) (Details) 35: R41 Investments (Amortized Cost And Fair Value Of HTML 64K Fixed Maturity Securities, By Contractual Maturity) (Details) 60: R42 Investments (Proceeds and Realized Gains Losses HTML 35K From Fixed Maturity Securities) (Details) 93: R43 Investments (Current and Long-term Equity HTML 38K Securities) (Details) 43: R44 Investments (Gains and Losses Recognized on Equity HTML 36K Securities) (Details) 34: R45 Investments (Securities Lending Programs) HTML 38K (Details) 59: R46 Investments (Narrative) (Details) HTML 38K 92: R47 Derivative Financial Instruments (Financial HTML 33K Statement Narrative) (Details) 42: R48 Fair Value (Fair Value Measurements By Level For HTML 144K Assets Measured At Fair Value On A Recurring Basis) (Details) 36: R49 Fair Value (Reconciliation Of The Beginning And HTML 75K Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs) (Details) 21: R50 Fair Value (Carrying And Estimated Fair Values by HTML 64K Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details) 49: R51 Income Taxes (Narrative) (Details) HTML 41K 76: R52 Retirement Benefits (Components Of Net Periodic HTML 52K (Benefit Credit) Benefit Cost) (Details) 64: R53 Medical Claims Payable (Reconciliation Of The HTML 79K Beginning And Ending Balances For Medical Claims Payable By Segment) (Details) 22: R54 Medical Claims Payable (Reconciliation Of Net HTML 43K Incurred Medical Claims To Benefit Expense) (Details) 50: R55 Medical Claims Payable Medical Claims Payable HTML 54K (Reconciliation of the Claims Development to the Claims Liability) (Details) 77: R56 Medical Claims Payable (Narrative) (Details) HTML 48K 65: R57 Debt (Convertible Debenture Details) (Details) HTML 48K 20: R58 Debt (Narrative) (Details) HTML 86K 51: R59 Commitments And Contingencies (Details) HTML 54K 95: R60 Capital Stock (Summary of Cash Dividend Activity) HTML 39K (Details) 62: R61 Capital Stock (Summary of Share Repurchases) HTML 40K (Details) 32: R62 Capital Stock (Summary of Stock Option Activity) HTML 68K (Details) 40: R63 Capital Stock (Nonvested Restricted Stock Activity HTML 54K Including Restricted Stock Units) (Details) 96: R64 Capital Stock (Fair Values of Options Granted HTML 39K During The Period Estimated Using Weighted-Average Assumptions) (Details) 63: R65 Capital Stock (Schedule Of Weighted-Average Fair HTML 33K Values Determined For The Periods) (Details) 33: R66 Capital Stock (Narrative) (Details) HTML 51K 41: R67 Accumulated Other Comprehensive Loss HTML 88K (Reconciliation Of The Components Of Accumulated Other Comprehensive Income) (Details) 98: R68 Accumulated Other Comprehensive Income (Other HTML 54K Comprehensive Income (Loss) Reclassification Adjustments) (Details) 61: R69 Accumulated Other Comprehensive Income (Loss) HTML 50K Accumulated Other Comprehensive Income Reclassification Adjustments (Details) 68: R70 Earnings Per Share (Denominator For Basic And HTML 36K Diluted Earnings Per Share) (Details) 81: R71 Earnings Per Share (Narrative) (Details) HTML 35K 46: R72 Segment Information (Financial Data By Reportable HTML 60K Segment) (Details) 18: R73 Segment Information Segment Information (Major HTML 54K Product Revenues for Each Reportable Segment) (Details) 67: R74 Segment Information (Reconciliation Of Reportable HTML 40K Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details) 80: R75 Segment Information (Reconciliation Of Reportable HTML 50K Segments Operating Gain To Income Before Income Tax Expense Included In The Consolidated Statements Of Income) (Details) 45: R76 Segment Information Segment Information HTML 29K (Narrative) (Details) 17: R77 Leases (Lease and Other Information) (Details) HTML 57K 70: R78 Leases (Reconciliation of Future Lease Payments to HTML 48K Total Lease Liabilities) (Details) 78: R79 Leases (Narrative) (Details) HTML 41K 30: XML IDEA XML File -- Filing Summary XML 183K 91: XML XBRL Instance -- antm-2020331x10q_htm XML 3.78M 97: EXCEL IDEA Workbook of Financial Reports XLSX 116K 11: EX-101.CAL XBRL Calculations -- antm-20200331_cal XML 275K 12: EX-101.DEF XBRL Definitions -- antm-20200331_def XML 1.13M 13: EX-101.LAB XBRL Labels -- antm-20200331_lab XML 2.50M 14: EX-101.PRE XBRL Presentations -- antm-20200331_pre XML 1.56M 10: EX-101.SCH XBRL Schema -- antm-20200331 XSD 244K 94: JSON XBRL Instance as JSON Data -- MetaLinks 508± 805K 88: ZIP XBRL Zipped Folder -- 0001156039-20-000028-xbrl Zip 436K
Exhibit |
• | for any institutional investor (as defined in our articles of incorporation), one share less than 10% of our outstanding voting securities; |
• | for
any non-institutional investor (as defined in our articles of incorporation), one share less than 5% of our outstanding voting securities; and |
• | for any person, one share less than the number of shares of our common stock or other equity securities (or a combination thereof) representing a 20% ownership interest in us. |
• | the division of the board of directors into three classes serving staggered terms of office of three years; |
• | provisions limiting the maximum number of directors to 19; |
• | provisions
requiring that, except in certain limited circumstances, the filling of any vacancy on the board of directors must be approved by a majority of continuing directors; and |
• | requirements for advance notice for raising business or making nominations at shareholders’ meetings. |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 4/29/20 | 8-K | ||
For Period end: | 3/31/20 | |||
7/29/09 | 10-Q, 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/21/24 Elevance Health, Inc. 10-K 12/31/23 153:25M 2/15/23 Elevance Health, Inc. 10-K 12/31/22 152:27M 2/01/23 Elevance Health, Inc. 424B3 2:775K Donnelley … Solutions/FA 1/30/23 Elevance Health, Inc. 424B3 1:712K Donnelley … Solutions/FA 10/27/22 Elevance Health, Inc. 424B3 2:650K Donnelley … Solutions/FA 10/26/22 Elevance Health, Inc. 424B3 1:584K Donnelley … Solutions/FA 4/28/22 Elevance Health, Inc. 424B3 2:637K Donnelley … Solutions/FA 4/26/22 Elevance Health, Inc. 424B3 1:589K Donnelley … Solutions/FA 2/16/22 Elevance Health, Inc. 10-K 12/31/21 153:26M 3/10/21 Elevance Health, Inc. 424B3 1:531K Donnelley … Solutions/FA 3/08/21 Elevance Health, Inc. 424B3 1:515K Donnelley … Solutions/FA 2/18/21 Elevance Health, Inc. 10-K 12/31/20 160:28M 11/05/20 Elevance Health, Inc. S-3ASR 11/05/20 5:511K Donnelley … Solutions/FA |